NM_198253.3:c.2058C>T
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_198253.3(TERT):c.2058C>T(p.Ile686Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000127 in 1,572,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.0000066   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  7.0e-7   (  0   hom.  ) 
Consequence
 TERT
NM_198253.3 synonymous
NM_198253.3 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.0420  
Publications
0 publications found 
Genes affected
 TERT  (HGNC:11730):  (telomerase reverse transcriptase) Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008] 
TERT Gene-Disease associations (from GenCC):
- pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- dyskeratosis congenita, autosomal dominant 2Inheritance: AR, AD, SD, Unknown Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Laboratory for Molecular Medicine
- acute myeloid leukemiaInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- dyskeratosis congenitaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Hoyeraal-Hreidarsson syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- melanoma, cutaneous malignant, susceptibility to, 9Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81). 
BP6
Variant 5-1279363-G-A is Benign according to our data. Variant chr5-1279363-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 2012462.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=-0.042 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TERT | NM_198253.3 | c.2058C>T | p.Ile686Ile | synonymous_variant | Exon 5 of 16 | ENST00000310581.10 | NP_937983.2 | |
| TERT | NM_001193376.3 | c.2058C>T | p.Ile686Ile | synonymous_variant | Exon 5 of 15 | NP_001180305.1 | ||
| TERT | NR_149162.3 | n.2137C>T | non_coding_transcript_exon_variant | Exon 5 of 13 | ||||
| TERT | NR_149163.3 | n.2137C>T | non_coding_transcript_exon_variant | Exon 5 of 13 | 
Ensembl
Frequencies
GnomAD3 genomes  0.00000657  AC: 1AN: 152158Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1
AN: 
152158
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00000566  AC: 1AN: 176814 AF XY:  0.00   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1
AN: 
176814
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  7.04e-7  AC: 1AN: 1419960Hom.:  0  Cov.: 33 AF XY:  0.00  AC XY: 0AN XY: 702908 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1
AN: 
1419960
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
0
AN XY: 
702908
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
32444
American (AMR) 
 AF: 
AC: 
0
AN: 
38710
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
25406
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
37358
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
80822
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
49164
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
4304
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1093046
Other (OTH) 
 AF: 
AC: 
0
AN: 
58706
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.425 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.00000657  AC: 1AN: 152158Hom.:  0  Cov.: 33 AF XY:  0.00  AC XY: 0AN XY: 74324 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
1
AN: 
152158
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
0
AN XY: 
74324
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41452
American (AMR) 
 AF: 
AC: 
0
AN: 
15286
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5170
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10628
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
68006
Other (OTH) 
 AF: 
AC: 
0
AN: 
2094
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.625 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2    Benign:1 
Dec 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.